ZELIRA THERAPEUTICS (ZLDAF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 14 24 sessions, August 11, 2025 to August 11, 2026
- Largest daily move
- +53.3% close of January 30, 2026
- 1-year change
- -13.1% closing prices, August 11, 2025 to August 11, 2026
- 1-month change
- -13.3% closing prices, July 6, 2026 to August 11, 2026
Company Description
ZELIRA THERAPEUTICS (OTC: ZLDAF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $3.4M.
ZLDAF has declined 13.1% over the past year. The last closing price was $0.2600.
This page collects what Stock Titan holds for ZLDAF, including price data, latest news, and short interest trends.
Stock Performance
ZELIRA THERAPEUTICS (ZLDAF) closed at $0.2600 on August 11, 2026. Over the past 12 months, the price has lost 13.1%.
ZLDAF Metrics & Rankings
Price returns through August 11, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
ZELIRA THERAPEUTICS has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all ZLDAF news →
SEC Filings
Short Interest History
Days to Cover History
ZLDAF Company Profile & Sector Positioning
ZELIRA THERAPEUTICS (ZLDAF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing ZLDAF often look at related companies in the same sector, including MOSAIC IMMUNOENGINEERING (CPMV), NASCENT BIOTECH INC (NBIO), APTOSE BIOSCIENCES INC (APTOF), AVENUE THERAPEUTICS INC (ATXI), and RESTART LIFE SCIENCES CP (NMLSF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ZLDAF's relative position within its industry.